Hey‐Chi Hsu

7.2k citations
106 papers · 5.8k indexed · h-index 44

Impact in

Papers in

Hey‐Chi Hsu

106 papers receiving 5.7k citations

Peers

Hey‐Chi Hsu
Comparison fields: 5 of 128
  • Hepatology 1.8k
  • Cancer Research 1.0k
  • Oncology 1.6k
  • Epidemiology 1.5k
  • Pathology and Forensic Medicine 627
Replace Takashi Maeda with:
Takashi Maeda Japan
Haeryoung Kim South Korea
Kenichi Harada Japan
Eunsil Yu South Korea
Shuji Nomoto Japan
Benoît Terris France
Han Chong Toh Singapore
Zhao‐Chong Zeng China
Dominique Vidaud France
Melissa P. Upton United States
Hey‐Chi Hsu relative to Takashi Maeda Japan Takashi Maeda's profile →
Citations per field
00.5×2.5×
Takashi Maeda · 1×
Citations per year

Countries citing papers authored by Hey‐Chi Hsu

Since Specialization
Citations

This map shows the geographic impact of Hey‐Chi Hsu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hey‐Chi Hsu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hey‐Chi Hsu more than expected).

Fields of papers citing papers by Hey‐Chi Hsu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hey‐Chi Hsu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hey‐Chi Hsu. The network helps show where Hey‐Chi Hsu may publish in the future.

Co-authors

The 25 scholars most cited alongside Hey‐Chi Hsu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Hey‐Chi Hsu Line = papers co-authored together Hey‐Chi Hsu links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1 201413
2 201326
3 201217
4 2008105
5 200877
6 2003216
7 200158
8 200023
9 200027
10 2000129
11 2000241
12 2000150
13 199935
14 19953
15 199483
16 19947
17 19891
18 19893
19 1989113
20 198721

About Hey‐Chi Hsu

Hey‐Chi Hsu is a scholar working on Hepatology, Cancer Research, Oncology, Epidemiology and Surgery, having authored 106 papers that have together received 5.8k indexed citations. Recurring topics across this work include Liver Disease Diagnosis and Treatment (18 papers), Hepatocellular Carcinoma Treatment and Prognosis (17 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (16 papers), Hepatitis B Virus Studies (14 papers), Pediatric Hepatobiliary Diseases and Treatments (9 papers), Cancer-related Molecular Pathways (8 papers), Cancer-related gene regulation (8 papers) and Viral-associated cancers and disorders (7 papers). The work is most often cited by research in Hepatology (1.8k citations), Cancer Research (1.0k citations), Oncology (1.6k citations), Epidemiology (1.5k citations) and Pathology and Forensic Medicine (627 citations). Hey‐Chi Hsu has collaborated with scholars based in Taiwan, United States and Japan. Frequent co-authors include Yung‐Ming Jeng, Shian‐Yang Peng, Po‐Lin Lai, Po‐Huang Lee, Jin‐Chuan Sheu, Ding‐Shinn Chen, Chiao‐Ying Lin, Ray‐Hwang Yuan, Pei–Ming Yang and Mei‐Hwei Chang. Their work appears in journals such as Cancer, Hepatology, Journal of Pediatric Gastroenterology and Nutrition, International Journal of Cancer and Clinical Cancer Research.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026